viernes, 23 de mayo de 2025
Benefits Persist With Inavolisib in PIK3CA-Mutated Breast Cancer Kate Johnson May 23, 2025 ++++++
https://www.medscape.com/viewarticle/benefits-persist-inavolisib-pik3ca-mutated-breast-cancer-2025a1000d1x
New ASCO AI Tool Promises Fast, Accurate Guidelines Access
Sharon Worcester, MA
May 23, 2025
https://www.medscape.com/viewarticle/new-asco-ai-tool-promises-fast-accurate-guidelines-access-2025a1000d1m
FDA Questions Value of Single-Arm Studies for Cancer Approvals
M. Alexander Otto, PA, MMS
May 23, 2025
https://www.medscape.com/viewarticle/fda-questions-value-single-arm-studies-cancer-approvals-2025a1000d1h
Conference MDAngle: ASCO 2025
Prostate Cancer
May 22, 2025
https://www.medscape.com/viewarticle/mdangle-asco-2025-prostate-cancer-overview-poll-2025a10000is
ASCO 2025: Anticipating Key Innovations in Prostate Cancer
Petros Grivas, MD, PhD
https://www.medscape.com/viewarticle/mdangle-asco-2025-prostate-cancer-preconference-thoughts-2025a10000f0
Conference MDAngle: ASCO 2025
Early Breast Cancer
May 22, 2025
https://www.medscape.com/viewarticle/mdangle-asco-2025-early-breast-cancer-overview-poll-2025a10002ju
| May 22, 2025
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario